
JUPW
Healthcare · Drug Manufacturers - Specialty & Generic · $49.3M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2023 | Time not confirmed | — | 0.00 | — |
| Aug 15, 2023 | Time not confirmed | — | -0.01 | — |
| Apr 3, 2023 | Time not confirmed | — | -0.39 | — |
| Nov 14, 2022 | Time not confirmed | — | -0.11 | — |
| Aug 15, 2022 | Time not confirmed | — | -0.07 | — |
| May 16, 2022 | Time not confirmed | — | -0.13 | — |
| Mar 31, 2022 | Time not confirmed | — | -0.71 | — |
| Nov 12, 2021 | Time not confirmed | — | -0.24 | — |
| Aug 16, 2021 | Time not confirmed | — | -0.37 | — |
| Apr 12, 2021 | Time not confirmed | — | -0.55 | — |
| Mar 31, 2021 | Time not confirmed | — | -0.20 | — |
| Oct 26, 2020 | Time not confirmed | — | -0.01 | — |
| Sep 30, 2020 | Time not confirmed | 0.00 | -0.09 | — |
Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its…
| Jun 17, 2020 |
| Time not confirmed |
| — |
| -0.12 |
| — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.07 | — |
| Dec 31, 2019 | Time not confirmed | 0.00 | -0.10 | — |
| Jul 29, 2019 | Time not confirmed | — | -0.01 | — |
| Jun 30, 2019 | Time not confirmed | 0.00 | -0.01 | — |
| Mar 31, 2019 | Time not confirmed | 0.00 | -0.01 | — |